Fig. 5From: MiR-105-3p acts as an oncogene to promote the proliferation and metastasis of breast cancer cells by targeting GOLIM4Silencing of GOLIM4 restores cell proliferation and migration and inhibits apoptosis induced by the downregulation of miR-105-3p. Either sh-NC or sh-GOLIM4 was transfected into miR-105-3p-downregulated MCF7 and ZR-75-30 cells, and the cells cotransfected with NC inhibitor and sh-NC were chosen as controls. a RT-qPCR analysis of the expression level of GOLIM4 in MCF-7 and ZR-75-30 cells after transfection with sh-NC or sh-GOLIM4. (B, C) CCK-8 and colony formation assays for cell viability and proliferation. d TUNEL assay for cell apoptosis. e Western blot analysis for related proteins that were involved in cell apoptosis. e Transwell chamber assay for cell migration and invasion. Asterisks indicate significant differences from the control (**P < 0.01, compared to the sh-NC and NC inhibitor+ sh-NC group. ##P < 0.01, compared to miR-105-3p miRNA inhibitor + sh-GOLIM4)Back to article page